REDHILL BIOPHARMA LTD has a total of 135 patent applications. It increased the IP activity by 71.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, China and Australia. Its main competitors in its focus markets pharmaceuticals, machines and measurement are INVERSEON INC, JIMENEZ BAYARDO ARTURO and CPEX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 30 | |
#2 | China | 10 | |
#3 | Australia | 8 | |
#4 | Canada | 8 | |
#5 | EPO (European Patent Office) | 8 | |
#6 | WIPO (World Intellectual Property Organization) | 8 | |
#7 | Israel | 7 | |
#8 | Republic of Korea | 7 | |
#9 | Mexico | 7 | |
#10 | Brazil | 6 | |
#11 | Singapore | 6 | |
#12 | Chile | 5 | |
#13 | Philippines | 5 | |
#14 | Hong Kong | 4 | |
#15 | South Africa | 4 | |
#16 | New Zealand | 3 | |
#17 | Hungary | 2 | |
#18 | India | 2 | |
#19 | Ukraine | 2 | |
#20 | Japan | 1 | |
#21 | Russian Federation | 1 | |
#22 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Fathi Reza | 107 |
#2 | Raday Gilead | 48 |
#3 | Goldberg Guy | 42 |
#4 | Mclean Patrick Laughlin | 25 |
#5 | Gosselin Patrick | 24 |
#6 | Abramson Danielle | 22 |
#7 | Ben-Asher Dror | 20 |
#8 | Reza Fathi | 14 |
#9 | Leighton Harry Jefferson | 13 |
#10 | Plasse Terry | 11 |
Publication | Filing date | Title |
---|---|---|
KR20200031567A | Use of WX-UK1 and its prodrug WX-671 for the treatment of non-cancerous medical conditions | |
RU2727474C2 | Types of combined therapy for cancer treatment | |
CN107106525A | Treatment for suppressing single strand RNA virus duplication | |
AU2015228545A1 | Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms | |
WO2014181195A2 | Antiemetic extended release solid dosage forms | |
MX2015010490A | Pharmaceutical compositions for the treatment of helicobacter pylori. | |
AU2013294737A1 | Formulations and methods of manufacturing formulations for use in colonic evacuation | |
TW201320999A | A composition and method for treating an autoimmune disease |